D-0614-2025 Class II Ongoing

Recalled by IMMUNOCORE, LLC — Conshohocken, PA

FDA drug recall D-0614-2025 was initiated by IMMUNOCORE, LLC on Jun 10, 2025 and is designated Class II. Reason for recall: Subpotent Drug The recall status is ongoing. Affected quantity: 7,572 vials.

Recall details

Product Type
Drugs
Report Date
Sep 10, 2025
Initiation Date
Jun 10, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7,572 vials

Product description

KIMMTRAK (tebentafusp-tebn) Injection, 100 mcg/0.5 mL, For intravenous Infusion After Dilution, Single-Does vial. Mfd by: Immunocore Limited, 92 Park Drive, Abingdon, Oxfordshire, OX14 4RY, United Kingdom, For: Immunocore Commercial LLC, 181 Washington St, Conshohocken, PA, 19428, Product of Denmark NDC 80446-0401-01 Lot #: 3D009AA09, 3D009AA10, 3D009AA25, Exp Date: 31 MAR 2026 NDC 80446-0401-99 (Non-Commercial FG) Lot #: 3D009AA02, Exp Date 31 MAR 2026

Reason for recall

Subpotent Drug

Distribution pattern

US Nationwide

Code information

NDC 80446-0401-01 Lot #: 3D009AA09, 3D009AA10, 3D009AA25, Exp Date: 31 MAR 2026 NDC 80446-0401-99 (Non-Commercial FG) Lot #: 3D009AA02, Exp Date 31 MAR 2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0614-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0614-2025. Report a data issue: hello@regdatalab.com.